Zogenix objects to new Massachusetts restrictions
BOSTON (AP) -- The San Diego company that makes a powerful new prescription painkiller called Zohydro says it’s disappointed with Massachusetts Gov. Deval Patrick’s decision to impose new restrictions on the drug after a federal judge ruled that his attempt to ban the drug outright was unconstitutional.
Zogenix, in statement issued Wednesday, said the governor continues to unfairly single out the drug even as the company maintains it is no riskier than other opioids currently on the market.
The company also said Patrick still has not accepted its offer to "discuss the facts" and work together to address the needs of patients while "combating abuse and addiction."
The governor on Tuesday announced new requirements for doctors prescribing Zohydro, such as completion of a risk assessment and "pain management treatment agreement" with the patient.
TALK TO US
If you'd like to leave a comment (or a tip or a question) about this story with the editors, please email us. We also welcome letters to the editor for publication; you can do that by filling out our letters form and submitting it to the newsroom.